MedTrace Logo

Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

NCT04692025 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-09-27

No results posted yet for this study

Summary

This study is to evaluate the effect of food on the pharmacokinetics of a single dose of ASC41 tablet in healthy volunteers, comparing fasting and postprandial pharmacokinetic parameters of Tmax, Cmax, AUC0-t, AUC0-∞.

Conditions

Interventions

DRUG

ASC41 tablet

Oral tablet

Sponsors & Collaborators

  • Hunan Provincial People's Hospital

    collaborator OTHER

  • Gannex Pharma Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-27
Primary Completion
2021-01-14
Completion
2021-01-21

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04692025 on ClinicalTrials.gov